Breaking

Trump shakes up NSA leadership, appoints new acting director and deputy to replace Biden appointees
Experts warn Iran’s nuclear double-talk designed to buy time, undermine US pressure
Democrat Rep Jared Golden says his party’s moving in ‘wrong direction’ on trade
Riverside Resources Receives Final Court Approval for Spin-Out of Blue Jay
CEOL Application Process Update
Crypto Market Recap: Trade Wars Shake Bitcoin, Hong Kong Welcomes Institutional Crypto Investors
Obama urges Americans to ‘possibly sacrifice’ in resisting Trump policies
In warning to Turkey, Israel hits strategic targets in Syria amid rising tensions

Politics
Business
World
Investing
Search for:

Investing

Completion of preclinical data package for RAD 402

December 10, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Completion of preclinical data package for RAD 402

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Riverside Resources Receives Final Court Approval for Spin-Out of Blue Jay

CEOL Application Process Update

Crypto Market Recap: Trade Wars Shake Bitcoin, Hong Kong Welcomes Institutional Crypto Investors

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (1,585)
- Investing (4,481)
- Politics (7,087)
- Uncategorized (3)
- World (5,788)

Disclaimer: startyourinvesting.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 startyourinvesting.com | All Rights Reserved

Top

Politics
Business
World
Investing

Type above and press Enter to search. Press Esc to cancel.